Sucampo Receives Marketing Authorization For Amitiza(R) In Switzerland For Treatment Of Chronic Idiopathic Constipation

Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC). (Source: GastroIntestinal News From Medical News Today) Go to Source

People who read this also read

• Amitiza(R) For Treatment Of Chronic Idiopathic Constipation
  Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorizatio...
• Human Genome Sciences Announces Submission Of Marketing Authorization Application To EMEA For JOULFERON(R) (ZALBIN™)
  Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that Novartis has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) for approval to market JOULFERON® (...
• Sanofi-aventis: Multaq(R) Approved In The European Union For Patients With Atrial Fibrillation
  Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the European Commission has granted marketing authorization for Multaq(R) (dronedarone 400mg Tablets) in all 27 European member states. Thi...
• ChemGenex’s Marketing Authorization Application For Omacetaxine Mepesuccinate Validated By The European Medicines Agency
  ChemGenex Pharmaceuticals Limited (ASX:CXS) announced that the European Medicines Agency ("EMEA") has determined that the Marketing Authorization Application ("MAA") for omacetaxine mepesuccinate for ...
• Ipsen’s Decapeptyl(R) 6-Month Formulation Receives Marketing Authorization For The Treatment Of Locally Advanced Or Metastatic Prostate Cancer
  Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAP...
• Basilea’s Toctino(R) Receives Marketing Authorization In Canada
  Basilea Pharmaceutica Ltd. announces that Toctino® (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has ...
• Compound Eases Constipation for Opioid Patients (CME/CE)
  SAN DIEGO (MedPage Today) -- An investigational compound increased spontaneous bowel movements for patients with opioid-induced constipation, researchers said here. (Source: MedPage Today Pain Managem...
• Constipation natural laxative
  Constipation is one of the most common gastro-intestinal ailments all over the world; though consulting a doctor for it is very uncommon unless severe. The fact that chemical laxatives do cause depend...
• Natural Remedies For Anal Fissures
  Anal fissure may be termed as a linear crack in the skin surrounding the anus which is the excretory opening from the bowel. It is usually associated with constipation and other bowel disorders. The i...
• Constipation in Children Causes, Symptoms, Diagnosis, Treatment,
  Constipation occurs commonly in children, affecting up to 10% at any given time. Still, only 3% of parents actually seek advice from the doctor for this condition. Constipation describes the infrequen...